PHR - Phreesia, Inc.
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Michael Rasbury, VP of AccessOne Solutions, named to Becker's Hospital Review's 2026 Rising Stars: Healthcare Leaders Under 40 list.
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has been named to TIME's list of the World's Top HealthTech Companies of 2026. This marks the second consecutive year Phreesia has been recognized on the list, which is developed in partnership with Statista to identify companies using technology to make healthcare more effective and accessible. The 2026 list recognizes companies worldwide across six health technology market segm.
Phreesia, Inc. (NYSE: PHR - Get Free Report) General Counsel Allison Hoffman sold 6,662 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $10.08, for a total value of $67,152.96. Following the transaction, the general counsel directly owned 266,574 shares in the company, valued at
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's ProviderConnect audiences are now available in the DeepIntent Audience Marketplace.
This added to lingering negative sentiment following the company's latest earnings release. Investors didn't like the fact that it whiffed on earnings.
Although its net income rose sharply, analysts expected better. On a brighter note, the company slightly topped the consensus pundit estimate for revenue.
Phreesia Inc (NYSE:PHR) on Wednesday reported mixed second-quarter financial results.
Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Phreesia (PHR) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.01 per share a year ago.
Phreesia NYSE: PHR reported second-quarter fiscal 2027 revenue growth and continued profitability expansion, while maintaining its full-year revenue and adjusted EBITDA outlook. The company said it generated positive operating and free cash flow for the ninth consecutive quarter and used its cash generation and available cash to reduce debt principal by more than $23 million.
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. “Phreesia delivered a solid fiscal second quarter, with revenue growth and profitability expansion in line with our expectations. We generated positive operating and free cash flow again this quarter, which together with available cash allowed us to reduce debt principal by over $23 million while maint.
Deutsche Bank AG bought a new position in shares of Phreesia, Inc. (NYSE: PHR) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 52,327 shares of the company's stock, valued at approximately $538,000. Deutsche Bank AG owned
Phreesia (NYSE: PHR - Get Free Report) and DarioHealth (NASDAQ: DRIO - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability and analyst recommendations. Institutional and Insider Ownership 92.1% of Phreesia shares are
Dimensional Fund Advisors LP lessened its holdings in Phreesia, Inc. (NYSE: PHR) by 22.9% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 484,717 shares of the company's stock after selling 143,563 shares during the period. Dimensional Fund Advisors LP
Phreesia, Inc. (NYSE: PHR - Get Free Report)'s stock price gapped up before the market opened on Friday. The stock had previously closed at $11.42, but opened at $12.60. Phreesia shares last traded at $12.8730, with a volume of 230,378 shares changing hands. Analysts Set New Price Targets Several research analysts have commented on the
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). The investigation seeks to determine whether the Company's leadership fulfilled its obligations to shareholders and whether legal remedies may be available.
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). The investigation seeks to determine whether the Company's leadership fulfilled its obligations to shareholders and whether legal remedies may be available.
EUDA Health (NASDAQ: EUDA - Get Free Report) and Phreesia (NYSE: PHR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk. Profitability This table compares EUDA Health and Phreesia's